ArticleFrontiers in immunology2022

DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells

Chiara Focaccetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.